Back to search
Chronic Thromboembolic Disease (CTED)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Thromboembolic Disease (CTED) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Thromboembolic Disease (CTED) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an open label study of Riociguat in patients with continued exercise intolerance at least 6 months following pulmonary endarterectomy (PEA).
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by obstruction of the pulmonary vasculature by residual organized thrombi, leading to inc…